| Patent application number | Description | Published |
|---|
| 20090060962 | COSMETIC USE OF BIFIDOBACTERIUM SPECIES LYSATE FOR THE TREATMENT OF DRYNESS - Cosmetic use of an effective amount of a lysate of at least one microorganism of the genus | 03-05-2009 |
| 20090068160 | USE OF A LYSATE OF BIFIDOBACTERIUM SPECIES FOR TREATING SENSITIVE SKIN - Cosmetic use of an effective amount of at least one lysate of at least one microorganism of the genus | 03-12-2009 |
| 20090068161 | USE OF A COMBINATION OF HESPERIDIN AND OF A MICROORGANISM FOR INFLUENCING THE BARRIER FUNCTION OF THE SKIN - The cosmetic use of at least an effective amount of hesperidin or of one of its derivatives in combination with at least an effective amount of at least one microorganism, in particular probiotic microorganism, or one of its fractions as agent for preventing a reduction in and/or for reinforcing the barrier function of the skin. | 03-12-2009 |
| 20100022648 | ORAL USE OF AT LEAST ONE MONOUNSATURATED FATTY ACID FOR HAIR IMPROVEMENT - The present invention relates to the cosmetic use by the oral route of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, preferably petroselinic acid, for improving the quality of the hair and/or the appearance of the hair, in particular for preventing and/or treating the changes of the scalp and/or of the hair that occur with age. | 01-28-2010 |
| 20100129324 | BIOLOGICAL EFFECTS OF COMPOSITIONS COMPRISING ROSMARINIC ACID - The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject. | 05-27-2010 |
| 20100203094 | COMBINATION OF A MICROORGANISM AND A PHYTOSPHINGOSINE DERIVATIVE, COMPOSITION, METHODS OF USE - At least one phytosphingosine salicylate derivative and at least one lysate of at least one microorganism of the genus | 08-12-2010 |
| 20100216707 | COSMETIC USE OF APOLIPOPROTEIN D TYPE PROTEINS - The subject of the present invention is the use, in particular the cosmetic and/or therapeutic use, of the apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, of a nucleic sequence encoding such a polypeptide or of an agent modulating the activity or of the expression of such a polypeptide, in particular for stimulating terminal epithelial differentiation. The invention also relates to the use of the protein apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, or of a nucleic sequence encoding such a polypeptide as a marker for evaluating the state of the epidermis. | 08-26-2010 |
| 20100272839 | TREATMENT OF FATTY SCALP WITH A LYSATE OF BIFIDOBACTERIUM SPECIES - The present invention treats a fatty dandruff state of the scalp with a lysate of at least one microorganism of the genus | 10-28-2010 |
| 20100278793 | TREATMENT OF GREASY SKIN WITH A BACTERIAL LYSTATE - The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genus | 11-04-2010 |
| 20100305053 | USE OF HESPERIDIN OR OF A DERIVATIVE THEREOF FOR THE PREVENTION AND/OR TREATMENT OF SLACKENED SKIN - The present invention relates to the oral use of an effective amount of hesperidin or of a derivative thereof as a skin finning agent. | 12-02-2010 |
| 20100311666 | COSMETIC USE OF A PROTEIN BELONGING TO THE RIBONUCLEASE FAMILY - The present invention relates to the use, in cosmetics and in therapeutics, of at least one antimicrobial protein belonging to the ribonuclease family, ribonuclease 7, or of polypeptides derived from said protein, notably as a marker for evaluating the condition of the epidermis. It further relates to the use of at least one polypeptide according to the invention, of at least one nucleic acid sequence coding for a polypeptide according to the invention, or of at least one agent that modulates the expression or the activity, notably biological, of said polypeptide or of its interaction with an element of the extracellular matrix, for the preparation of compositions intended for the prevention and/or treatment of skin disorders. | 12-09-2010 |
| 20110014248 | Cosmetic use of microorganism(s) for the treatment of scalp disorders - The present invention relates to a use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof for preventing and/or treating dandruff disorders of the scalp, as well as a cosmetic process for preventing and/or treating a dandruff condition including the administration a first cosmetic active agent and of at least a second cosmetic active agent, topically, the said first and second cosmetic active agents being formulated in separate compositions, the first cosmetic active agent being chosen from probiotic microorganisms, and mixtures thereof, and the second cosmetic active agent being chosen from antidandruff active agents. | 01-20-2011 |
| 20110091439 | COSMETIC USE OF ACID CERAMIDASE TYPE PROTEINS - A method for preventing and/or treating the signs of skin aging comprises administering as an agent into an individual in need thereof an effective amount of acid ceramidase, polypeptides derived from this protein or analogues thereof, a nucleic sequence encoding such a polypeptide, or an agent for modulating the expression or the biological or biochemical activity of such a polypeptide. A methods for characterizing a state of an epithelium comprises determining a content of acid ceramidase, polypeptides derived from this protein or analogues thereof, or a nucleic sequence encoding such a polypeptide in an epidermis sample. | 04-21-2011 |
| 20110098230 | COSMETIC USE OF ANNEXIN II-TYPE PROTEINS FOR TREATING DRYNESS OF THE SKIN - The present invention relates to the use, in particular cosmetic and/or therapeutic use, of annexin II, of polypeptides derived from this protein or of analogues thereof, of a nucleic sequence encoding such a polypeptide or of a modulator of the activity, the stability or the expression of such a polypeptide, in particular for preventing and/or treating the signs of skin dryness. | 04-28-2011 |
